Kerry Holford

Stock Analyst at Berenberg Bank

(4.04)
# 1,737
Out of 5,125 analysts
204
Total ratings
59.2%
Success rate
8.7%
Average return

Stocks Rated by Kerry Holford

GSK plc
Nov 3, 2026
Reiterated: Buy
Price Target: 2,200p
Current: 1,917p
Upside: +14.76%
Eli Lilly and Company
Oct 20, 2026
Reiterated: Buy
Price Target: $1,400
Current: $1,432.29
Upside: -2.25%
Pfizer
Oct 20, 2026
Reiterated: Hold
Price Target: $25
Current: $29.36
Upside: -14.85%
Novo Nordisk
Oct 13, 2026
Reiterated: Hold
Price Target: $47
Current: $40.70
Upside: +15.48%
Novartis AG
Oct 5, 2026
Reiterated: Hold
Price Target: CHF 105.00
Current: CHF 134.48
Upside: -21.92%
Novartis AG
Jul 27, 2026
Reiterated: Hold
Price Target: $141 → $147
Current: $163.26
Upside: -9.96%
GSK plc
Nov 25, 2025
Reiterated: Hold
Price Target: $41 → $43
Current: $51.23
Upside: -16.06%
Sanofi
May 16, 2025
Reiterated: Buy
Price Target: €105.00 → €120.00
Current: €85.95
Upside: n/a
The Estée Lauder Companies
Mar 24, 2025
Reiterated: Hold
Price Target: $65 → $60
Current: $113.43
Upside: n/a
Team Internet Group plc
Mar 24, 2025
Reiterated: Buy
Price Target: 100p
Current: 33p
Upside: n/a
Reiterated: Hold
Price Target: €150.00
Current: €149.35
Upside: n/a